Noxilizer, Sterigenics ink exclusive sterilization deal

Noxilizer and Sterigenics said today they inked a global trade agreement which will position Sterigenics as the exclusive provider of Noxilizer’s nitrogen dioxide contract sterilization services and feasibility and research studies for pharma, biotech and med device firms. Baltimore, Md.-based Noxilizer said it expects to have the 1st NO2 sterilization systems operational at Sterigenics facilities

Nanotronics raises $30 million for automated microscope tech

Nanotronics – which boasts what it says is the world’s most advanced automated microscopes – said today that it has raised $30 million – bringing its total money raised to $71 million. The Investment Corporation of Dubai (ICD) led the Series D round, with participation from current investor Founders Fund. The money will accelerate development of Nanotronics’ optical

Mellon Medical raises nearly $7 million for suturing tech

Dutch suturing tech company Mellon Medical said today that it has raised €6 million (equivalent to about $6.6 million) to advance its Switch instrument. Mellon Medical officials boast that their Switch single use precision-suturing instrument enables surgeons to suture tubular and layered structures about twice as fast as conventional methods. Reduced clamp time for many cardiovascular procedures

Abbott’s $5B acquisition of Alere set to close tomorrow

Abbott (NYSE:ABT) said today it is looking to close its $5 billion acquisition of Alere (NYSE:ALR) tomorrow, saying it has received all regulatory clearances necessary. The Abbott Park, Ill.-based company said the acquisition will establish it as a “global leader in point of care testing,” which it sees as the fastest growing segment of the $50 billion in vitro […]

4 top medtech stories you need to know in late 2017

The U.S. government continues to create a lot of uncertainty for the medical device industry, but medtech companies are still making some big moves. The frenzy of major mergers continues, which makes sense from an investor standpoint when it comes to reducing risk. Meanwhile, companies from outside the industry – including such high-tech giants as Apple,

Pages: 1 2 3 4 5

Medtech stories we missed this week: Sept. 29, 2017

From EOI getting FDA clearance to Sanuwave’s new joint venture agreement, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. EOI wins FDA nod for FLXfit15 expandable cage EOI announced in a Sept. 28 press release that it has received FDA 510(k) clearance for its FLXfit 15. The clearance

Promaxo closes $3.5 million Series A for office-based, high-res MRI

Promaxo said today that it closed a $3.5 million Series A round to fund its clinical validation and regulatory efforts for the company’s office-based, high-resolution MRI. MicroPort Scientific led the round and in connection with its investment, MicroPort was given exclusive manufacturing and distribution rights for Promaxo’s MRI tech in China. Get the full story at

Humacyte lands $14 million to expand uses for human acellular vessel

Humacyte said today that it landed a $14.1 million award from the California Institute for Regenerative Medicine to support a clinical trial comparing its human acellular vessel, Humacyl, to arteriovenous fistulas – the traditional way to create vascular access in patients who need hemodialysis. The Research Triangle Park, N.C.–based company said it plans to evaluate Humacyl

Should the medical device industry pay user fees to CMS?

Achieving reimbursement from payers has become a major challenge for medical device companies. Could the solution lie in having them pay user fees to CMS – the way they do to FDA? That was the question floated by Nadim Yared, president of CVRx and the current chairman of AdvaMed, during this week’s Medtech Conference powered by

FDA seeking to prevent medical device shortages from hurricanes

The U.S. FDA has been seeking to prevent shortages of medical devices and other products after disruptions caused by Hurricanes Harvey, Irma and Maria. “These storms have hit hard in areas where there are a significant number of farmers, food distributors, and medical product manufacturers, including Houston, Florida, and now Puerto Rico and the U.S.

How Abbott is making good on investor promises

Abbott (NYSE: ABT) has won FDA approval of MR-compatible ICDs – an indication that it could be making good executing on key priorities it inherited when it acquired St. Jude Medical for $25 billion early this year. The news today “lends incremental credibility to our thesis that ABT can and will have a positive impact on STJ

DeviceTalks Boston: Here’s what you need to know

DeviceTalks Boston on Oct 2. will give attendees the chance to see some of the best minds in medtech live. There will be learning and networking opportunities galore. Read on and meet some of the top medical device leaders and experts who will be speaking – and discover other highlights from the upcoming show.   Next>> (See

Pages: 1 2 3 4 5 6 7 8

The startup pivot: How to rethink your medical device company

In the medtech market, startups have to be flexible; the startup pivot is crucial. “Companies have to morph as they go,” said Maria Palasis, CEO of bioresorbable drug delivery system company 480 Biomedical. Palasis explained that startups, and even mature companies should expect to shift their technology in one way or another through the course of

The 10 largest medical device companies in the world

Mergers & acquisitions continue to change the medical device landscape, as reflected in Medical Design & Outsourcing’s new Big 100 list. We pulled financial regulatory filings and reached out to major companies in some cases to create a list of the 100 largest medical device companies in the world, ranked by annual revenue for their

Pages: 1 2 3 4 5 6 7 8 9 10 11

Hurricane Maria poses threat to med device hub in Puerto Rico

Hurricane Maria is posing a threat to medical device and pharmaceutical manufacturing plants in Puerto Rico, according to a new Bloomberg report. The island is home to facilities for Johnson & Johnson (NYSE:JNJ), Pfizer (NYSE:PFE), Amgen (NSDQ:AMGN), Merck, Medtronic (NYSE:MDT) , Abbott (NYSE:ABT), Stryker (NYSE:SYK) and dozens of others, according to the report. Most of the companies created facilities in Puerto Rico due to tax incentives, Bloomberg reports.